<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1104</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2008-4-2-57-61</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак предстательной железы</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Definition of the efficacy of prostate cancer treatment within the near terms</article-title><trans-title-group xml:lang="ru"><trans-title>Определение эффективности лечения рака предстательной железы в ближайшие сроки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vazhenin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Важенин</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karnauh</surname><given-names>P. A.</given-names></name><name xml:lang="ru"><surname>Карнаух</surname><given-names>П. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Chelyabinsk regional oncologic clinic, Russian scientific center of radiology and nuclear medicine</institution></aff><aff><institution xml:lang="ru">ГЛПУ Челябинский областной онкологический диспансер</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="ru">клиническая база ФГУ Российский научный центр рентгенорадиологии Росздрава</institution></aff><aff><institution xml:lang="en">Chelyabinsk regional oncologic clinic, Russian scientific center of radiology and nuclear medicine</institution></aff></aff-alternatives><aff id="aff3"><institution>ГЛПУ Челябинский областной онкологический диспансер</institution></aff><aff id="aff4"><institution>клиническая база ФГУ Российский научный центр рентгенорадиологии Росздрава</institution></aff><pub-date date-type="pub" iso-8601-date="2008-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2008</year></pub-date><volume>4</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>57</fpage><lpage>61</lpage><history><date date-type="received" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1104">https://oncourology.abvpress.ru/oncur/article/view/1104</self-uri><abstract xml:lang="en"><p>In view of necessity to execute the complex estimation of the methods of the prostate cancer (PC) treatment within the near terms, an integral value of the treatment efficacy is suggested – coefficient of the treatment efficacy. To calculate it the one needs to know a value of increase of the prostate specific antigen level, prostate volume, residual urine amount and the value of the scale of estimation of disturbances of urination IPSS for a fixed time. Coefficient of the treatment efficacy is calculated by calculating of the quotient of the product of the values increases by the sum of the valued increases. To standardize estimation of the treatment efficacy, the calculation of scale of the efficacy with evaluating low, medium and high levels of efficacy is performed. Estimation of the different variants of treatment of PC depending on advance of the pathologic process in 468 patients is executed.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Ткачев С.И. Лучевая терапия рака предстательной железы. Клиническая онкоурология. Под ред. Б.П. Матвеева. М., Вердана; 2003. с. 525–46.</mixed-citation><mixed-citation xml:lang="ru">Ткачев С.И. Лучевая терапия рака предстательной железы. Клиническая онкоурология. Под ред. Б.П. Матвеева. М., Вердана; 2003. с. 525–46.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Michalski J.M. External beam radiation therapy. Prostate cancer: Principles and practice. Ed. by P.W. Kantoff, P.R. Carroll, A.V. D'Amico. Philadelphia, Baltimore, LWW; 2002. p. 317–35.</mixed-citation><mixed-citation xml:lang="ru">Michalski J.M. External beam radiation therapy. Prostate cancer: Principles and practice. Ed. by P.W. Kantoff, P.R. Carroll, A.V. D'Amico. Philadelphia, Baltimore, LWW; 2002. p. 317–35.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Partin A.W., Yoo J., Carter H. et al. The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110–14.</mixed-citation><mixed-citation xml:lang="ru">Partin A.W., Yoo J., Carter H. et al. The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110–14.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Partin A.W., Kattan M.W., Subong E.N. et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997;18:1445–51.</mixed-citation><mixed-citation xml:lang="ru">Partin A.W., Kattan M.W., Subong E.N. et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997;18:1445–51.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Roach M., Pickett B., Rosenthal S.A. et al. Defining treatment margins for six field conformal irradiation of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 1994;28:267–75.</mixed-citation><mixed-citation xml:lang="ru">Roach M., Pickett B., Rosenthal S.A. et al. Defining treatment margins for six field conformal irradiation of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 1994;28:267–75.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. WHO handbook for reporting results of cancer treatment. Geneva (Switzerland). World Health Organization Offset Publication _ 48. Geneva; 1979.</mixed-citation><mixed-citation xml:lang="ru">WHO handbook for reporting results of cancer treatment. Geneva (Switzerland). World Health Organization Offset Publication _ 48. Geneva; 1979.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92(3):205–16.</mixed-citation><mixed-citation xml:lang="ru">Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92(3):205–16.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Матвеев Б.П., Бухаркин Б.В., Матвеев В.Б. Рак предстательной железы. М.; 1999.</mixed-citation><mixed-citation xml:lang="ru">Матвеев Б.П., Бухаркин Б.В., Матвеев В.Б. Рак предстательной железы. М.; 1999.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
